Menü
sharewise zieht um Am Wochenende vom 22./23. August wird das neue sharewise die Hauptseite. Schau es dir jetzt an und sag uns, was dir fehlt. Zum neuen sharewise Was sich ändert
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Roth Mkm 

Calamp Corp. diskutieren

Calamp Corp.

WKN: A0B7RX / Symbol: CAMP / Name: CalAmp / Aktie / Telekommunikationsdienstleistungen / Small Cap /

0,13 €
2,13 %

Einschätzung Buy
Rendite (%) -78,14 %
Kursziel 5,56
Veränderung
Endet am 29.08.24

CalAmp Corp. (NASDAQ: CAMP) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $6.00 price target on the stock.
Ratings data for CAMP provided by MarketBeat

Einschätzung Buy
Rendite (%) -55,82 %
Kursziel 4,75
Veränderung
Endet am 06.10.24

CalAmp Corp. (NASDAQ: CAMP) had its price target lowered by analysts at Roth Mkm from $6.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for CAMP provided by MarketBeat

CalAmp Corp. (NASDAQ: CAMP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CAMP provided by MarketBeat

CalAmp Corp. (NASDAQ: CAMP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CAMP provided by MarketBeat

CalAmp Corp. (NASDAQ: CAMP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CAMP provided by MarketBeat

CalAmp Corp. (NASDAQ: CAMP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CAMP provided by MarketBeat

CalAmp Corp. (NASDAQ: CAMP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CAMP provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 5,63
Veränderung
Endet am 10.06.27

CAMP4 Therapeutics (CAMP) was given a new $6.50 price target by Chardan Capital. They now have a "buy" rating on the stock.
Ratings data for CAMP provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 7,77
Veränderung
Endet am 16.06.27

CAMP4 Therapeutics (CAMP) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $9.00 price target on the stock, up from $5.00.
Ratings data for CAMP provided by MarketBeat

CAMP4 Therapeutics (CAMP) had its "overweight" rating reaffirmed by Piper Sandler.
Ratings data for CAMP provided by MarketBeat